FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION

药物发现、开发和转化论坛

• 批准号: 8838373
• 负责人: Anne B Claiborne
• 金额: $ 9.98万
• 依托单位: NATIONAL ACADEMY OF SCIENCES
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-12 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8838373
• 关键词: FORUM; DRUG; DISCOVERY; DEVELOPMENT; TRANSLATION

Project Summary The Forum on Drug Discovery, Development, and Translation provides a unique platform for dialogue and collaboration among thought leaders and stakeholders in government, academia, industry, foundations, and patient advocacy. The Forum brings together leaders from private sector sponsors of biomedical and clinical research, federal agencies sponsoring and regulating biomedical and clinical research, the academic community, and patients, and in doing so serves to educate the policy community about issues where science and policy intersect. The purpose is to encourage dialogue and discussion across sectors and institutions, and to illuminate issues, but not necessarily resolve them. The Forum membership identifies topics that it wishes to address, and with assistance from staff, develops public meetings, internal discussions, symposia, and collaborations. The Forum does not provide advice or recommendations on any specific issue or policy pending before any government agency; summary reports will result from the public conferences. The Forum convenes several times each year to identify and discuss key problems and strategies in the discovery, development, and translation of drugs. To supplement the perspectives and expertise of its members, the Forum also holds public workshops to engage a wide range of experts, members of the public, and the policy community. The Forum's public meetings focus substantial public attention on critical areas of drug development. Summaries of these meetings are disseminated to the public via printed reports and the internet. In addition to large public workshops, Forum activities include discussion series addressing biomedical science and policy, and public engagement in the drug development process, which provide opportunities to engage policymakers, opinion leaders, and the public in an informal setting. A combination of Forum members and outside experts comprise several workgroups that examine high-priority issues in depth. In addition, the Forum commissions or develops papers to undertake new research as well as synthesize existing literature and explore scientific and policy issues on selected topics. The Forum also fosters collaborations among its members and constituencies.

项目摘要 药物发现，开发和翻译论坛提供了一个独特的 思想领袖和利益攸关方之间对话与合作的平台， 政府、学术界、工业界、基金会和患者倡导。论坛带来 来自生物医学和临床研究私营部门赞助商的领导人， 赞助和管理生物医学和临床研究的联邦机构， 学术界和病人，并在这样做有助于教育政策， 科学与政策交叉的问题。目的是 鼓励跨部门和机构的对话和讨论， 问题，但不一定能解决。论坛成员确定其 希望解决，并与工作人员的协助下，制定公开会议，内部 讨论、座谈会和合作。论坛不提供咨询或 就有待任何政府处理的任何具体问题或政策提出建议 公共会议将产生摘要报告。 该论坛每年举行几次会议，以确定和讨论关键问题， 在药物的发现，开发和翻译的战略。补充 论坛还举办公开研讨会， 让广泛的专家、公众和政策界参与进来。的 论坛的公开会议使公众高度关注毒品问题的关键领域 发展这些会议的摘要通过印刷品分发给公众， 报告和互联网。除了大型公共研讨会外，论坛的活动还包括 生物医学科学和政策以及公众参与的系列讨论 药物开发过程，为决策者参与提供了机会， 意见领袖和公众在一个非正式的设置。论坛成员的组合 和外部专家组成了几个工作组， 深入此外，论坛委托编写或编写文件， 研究和综合现有文献，探讨科学和政策问题 在选定的主题。论坛还促进其成员之间的合作， 选区